120 related articles for article (PubMed ID: 17270168)
1. The clinical utility of Lens culinaris agglutinin-reactive thyroglobulin ratio in serum for distinguishing benign from malignant conditions of the thyroid.
Shimizu K; Nakamura K; Kobatake S; Satomura S; Maruyama M; Kameko F; Tajiri J; Kato R
Clin Chim Acta; 2007 Apr; 379(1-2):101-4. PubMed ID: 17270168
[TBL] [Abstract][Full Text] [Related]
2. Discrimination of thyroglobulin from thyroid carcinoma tissue and that from benign thyroid tissues with use of competitive assay between lectin and anti-thyroglobulin antibody.
Shimizu K; Nakamura K; Kobatake S; Satomura S; Maruyama M; Tajiri J; Kato R
Rinsho Byori; 2007 May; 55(5):428-33. PubMed ID: 17593687
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a new method for the diagnosis of alterations of Lens culinaris agglutinin binding of thyroglobulin molecules in thyroid carcinoma.
Kanai T; Amakawa M; Kato R; Shimizu K; Nakamura K; Ito K; Hama Y; Fujimori M; Amano J
Clin Chem Lab Med; 2009; 47(10):1285-90. PubMed ID: 19743952
[TBL] [Abstract][Full Text] [Related]
4. [Thyroglobulin levels in needle lymph node cytology for the detection of papillary thyroid cancer recurrence].
Véliz J; Brantes S; Ramos C; Aguayo J; Cáceres E; Herrera M; Barber A; Barría M; Wohllk N
Rev Med Chil; 2008 Sep; 136(9):1107-12. PubMed ID: 19030653
[TBL] [Abstract][Full Text] [Related]
5. The role of estimation of the ratio of preoperative serum thyroglobulin to the thyroid mass in predicting the behaviour of well differentiated thyroid cancers.
Sharma AK; Sarda AK; Chattopadhyay TK; Kapur MM
J Postgrad Med; 1996; 42(2):39-42. PubMed ID: 9715297
[TBL] [Abstract][Full Text] [Related]
6. Circulating thyroglobulin mRNA does not predict early and midterm recurrences in patients undergoing thyroidectomy for cancer.
Lombardi CP; Bossola M; Princi P; Boscherini M; La Torre G; Raffaelli M; Traini E; Salvatori M; Pontecorvi A; Bellantone R
Am J Surg; 2008 Sep; 196(3):326-32. PubMed ID: 18614150
[TBL] [Abstract][Full Text] [Related]
7. Thyroglobulin: a specific serum marker for the management of thyroid carcinoma.
Whitley RJ; Ain KB
Clin Lab Med; 2004 Mar; 24(1):29-47. PubMed ID: 15157556
[TBL] [Abstract][Full Text] [Related]
8. Measuring thyroglobulin and thyroglobulin autoantibody in patients with differentiated thyroid cancer.
Spencer CA; Lopresti JS
Nat Clin Pract Endocrinol Metab; 2008 Apr; 4(4):223-33. PubMed ID: 18268520
[TBL] [Abstract][Full Text] [Related]
9. [Serum thyroglobulin in thyroid cancer and other thyroid diseases].
Demidchik EP; Kruglova NE; Minaĭlo TI; Gauptman AE; Koren' TA; Gedrevich ZE; Sevkovskiĭ IaI
Lab Delo; 1990; (7):16-8. PubMed ID: 1699058
[TBL] [Abstract][Full Text] [Related]
10. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.
Giovanella L; Ceriani L; Suriano S; Ghelfo A; Maffioli M
Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882
[TBL] [Abstract][Full Text] [Related]
11. [Thyroglobulin: usefulness and limits in monitoring patients with thyroid carcinoma].
Hammami H; Sellem A; Ben Sellem D; Aouni Z; Elabri SB; Mezigh C; Machghoul S; Ben Brahim H
Tunis Med; 2007 Feb; 85(2):128-30. PubMed ID: 17665659
[TBL] [Abstract][Full Text] [Related]
12. [Tumor markers for endocrine neoplasms].
Okamoto T
Gan To Kagaku Ryoho; 2001 Apr; 28(4):561-5. PubMed ID: 11329795
[TBL] [Abstract][Full Text] [Related]
13. The additive clinical value of combined thyroglobulin and antithyroglobulin antibody measurements to define persistent and recurrent disease in patients with differentiated thyroid cancer.
Aras G; Gültekin SS; Küçük NO
Nucl Med Commun; 2008 Oct; 29(10):880-4. PubMed ID: 18769305
[TBL] [Abstract][Full Text] [Related]
14. Serum thyroglobulin measurement: clinical background and main methodological aspects with clinical impact.
Iervasi A; Iervasi G; Carpi A; Zucchelli GC
Biomed Pharmacother; 2006 Sep; 60(8):414-24. PubMed ID: 16959467
[TBL] [Abstract][Full Text] [Related]
15. Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy.
Giovanella L; Ceriani L; Ghelfo A; Maffioli M; Keller F
Clin Endocrinol (Oxf); 2007 Oct; 67(4):547-51. PubMed ID: 17561976
[TBL] [Abstract][Full Text] [Related]
16. The usefulness of detecting thyroglobulin in fine-needle aspirates from patients with neck lesions using a sensitive thyroglobulin assay.
Sigstad E; Heilo A; Paus E; Holgersen K; Grøholt KK; Jørgensen LH; Bogsrud TV; Berner A; Bjøro T
Diagn Cytopathol; 2007 Dec; 35(12):761-7. PubMed ID: 18008339
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of postsurgical stimulated thyroglobulin levels after initial radioactive iodine therapy in well-differentiated thyroid carcinoma.
Sawka AM; Orlov S; Gelberg J; Stork B; Dowar M; Shaytzag M; Tabatabaie V; Freeman JL; Walfish PG
Head Neck; 2008 Jun; 30(6):693-700. PubMed ID: 18098308
[TBL] [Abstract][Full Text] [Related]
18. A method to differentiate between thyroglobulin derived from normal thyroid tissue and from thyroid carcinoma based on analysis of reactivity to lectins.
Maruyama M; Kato R; Kobayashi S; Kasuga Y
Arch Pathol Lab Med; 1998 Aug; 122(8):715-20. PubMed ID: 9701333
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of peripheral thyrotropin receptor mRNA in follow-up of differentiated thyroid cancer.
Milas M; Barbosa GF; Mitchell J; Berber E; Siperstein A; Gupta M
Ann Surg Oncol; 2009 Feb; 16(2):473-80. PubMed ID: 19015922
[TBL] [Abstract][Full Text] [Related]
20. Lessons from a review of thyroglobulin assays in the management of thyroid cancer.
Wong J; Lu Z; Doery J; Fuller P
Intern Med J; 2008 Jun; 38(6):441-4. PubMed ID: 18613899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
